Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Total Takes Stake In Amyris
by Marc S. Reisch
June 28, 2010
| A version of this story appeared in
Volume 88, Issue 26
French oil giant Total has taken a 17% stake in industrial biotechnology firm Amyris and will have one representative on the U.S. firm’s board. Terms were not disclosed, but Amyris CEO John Melo says the Total stake represents a new infusion of cash and doesn’t change Amyris’ plans to raise $100 million in an initial public offering (C&EN, April 26, page 9). In separate deals, Amyris will link with French cosmetic ingredients maker Soliance to make the moisturizer squalane, supply farnesene to Procter & Gamble for specialty chemicals, and provide farnesene to Italy’s M&G to blend into polyethylene terephthalate.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X